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A B S T R A C T
Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To assess the eCects of pressure redistributing static chairs on the prevention of pressure ulcers in health, rehabilitation, social care
settings, and places of residence in which people may spend their day.
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B A C K G R O U N D
Description of the condition
Pressure ulcers are a global issue that have serious consequences
for those people aCected and for health systems more widely. A
pressure ulcer is defined as "localized injury to the skin and/or
underlying tissue usually over a bony prominence, as a result of
pressure, or pressure in combination with shear" (NPIAP 2016).
Historically, the term pressure ulcer has changed from bedsore,
decubitus ulcer, and pressure sore, to pressure ulcer and pressure
injury. In Europe the term pressure ulcer has been adopted; whilst
in North America, Asia, and Australasia the term pressure injury is
preferred.
Pressure ulcer severity is staged or categorised from 1 to 4
(EPUAP 2014; NPIAP 2016; WHO 2018). The higher the category
the more significant the pressure ulcer and damage to the skin
and underlying tissues, with stage/category 1 indicating superficial
damage with no open wound and stage/category 4 indicating
significant damage through the layers of the skin, soH tissue, and
muscle, oHen exposing bone.
Prevalence estimates for pressure ulceration vary according to the
population being assessed, the data collection methods used, and
decisions about whether or not category I pressure ulcers should be
included (since there is no open wound at this stage but evidence
of possible tissue damage). Current estimates of the prevalence
of pressure ulcers from a systematic review of the data vary from
0.056% to 23% (Cullum 2016). The point prevalence of pressure
ulceration in the total adult population was estimated in literature
produced between 1997 to 2009 using a cross-sectional survey
undertaken in Leeds, UK. Of the total adult population of 751,485,
the point prevalence of pressure ulceration per 1000 was 0.31
(Cullum 2016). UK pressure ulcer prevalence estimates specifically
for community settings have reported rates of 0.77 per 1000 adults
in a UK urban area (Stevenson 2013).
The financial implications of pressure ulceration to health services
is large, and estimated across countries as from EUR 12.58 million to
EUR 240.94 million for prevention, to EUR 121.44 million to EUR 2.59
billion for treatment (Demarré 2015). A recent retrospective cohort
analysis found that UK National Health Service (NHS) community
costs of pressure ulcer treatment ranged from GBP 1400 for a
category 1 ulcer to over GBP 8500 for the other categories (Guest
2018).
Being seated with no or limited movement increases the risk of
pressure ulceration as soH tissues are compressed between two
surfaces, the seat and the bones of the pelvis, for long periods
(Krouskop 1983; Schubert 1994). This starves the area of oxygen and
nutrients and, if pressure is unrelieved, skin begins to break down
(Kosiak 1959). The risk of ulceration and rate of development can
vary, as high pressures over a short period of time can be equally
as destructive as low pressures over a longer period (Gefen 2008).
Damage from shear occurs when layers of the skin are laterally
shiHed in relation to each other because of limited movement
across a surface. Immobilisation or reduced mobility are risk factors
for pressure ulceration, as is reduced bodily sensation; other
suggested risk factors include unmanaged incontinence (resulting
in constantly moist skin), poor circulation, and poor nutrition
(Bhattacharya 2015; Bartley 2017). A pressure ulcer can begin with
inflamed, sore, painful skin. However, if a person has reduced
bodily sensation, the initial feelings of soreness are not felt and an
open wound could be the first signs of skin damage.
There are approximately 131,800,000 wheelchair users worldwide
who are not ambulant and are at increased risk for the development
of a pressure ulcer (Wheelchair Foundation 2019). Also at risk of
ulceration are those who have limited mobility and sit in static
chairs for extended periods of time, for example elderly and frail
populations: the number of people in this at-risk group is diCicult
to estimate but likely to be very large. For some patients, sitting
can be viewed as a therapeutic intervention and an important part
of a patient's recovery process; but the risk of ulceration also has
to be mitigated. Interventions for ulcer prevention in those at risk
from prolonged sitting include the use of specialist cushions and
surfaces (such as reactive and active, powered and non-powered
devices (NPIAP 2019)), especially in wheelchair users (Bartley 2017;
Stephens 2017). There is also increased interest in the eCects
of diCerent pressure-redistributing static chairs on pressure ulcer
development in at-risk people.
Description of the intervention
Pressure redistributing static chairs as devices for those who
remain seated for extended periods of time due to short- or long-
term mobility issues, or both, are used in many settings, including
hospitals, care homes, and people's own homes. They are an
essential part of the 24-hour postural management programme
for this population, and are considered a key assistive device
for promoting independence and function (Bartley 2017; Harrand
2016; Stephens 2017). There are many diCerent types of static chair
available for use in a healthcare context, with various levels of
pressure redistributing technology: ranging from standard hospital
chairs and chairs used in residential settings with no redistribution
function, to those that include foam, gel, air, or water with the aim
of reducing pressure on soH tissue. These can include:
• static arm chairs, known as a high-back chair, which is a
high-seat chair with an upright seating position. It comes
with additional lumbar support, optional wings (side pieces
projecting from the back of the chair) and arms that can
be upholstered in antimicrobial vinyls and fabric upholstery
options and a removable seat cushion;
• recliner chair: a high-back chair, which is a high-seat chair with
a sculpted or waterfall (sloping) back that reclines when the
occupant lowers the chair's back and raises its front. It has a
backrest that can be tilted back, and oHen a footrest that may
be extended by means of a lever on the side of the chair, or may
extend automatically when the back is reclined. It can also have
liH and tilt actions;
• riser: a recliner chair (single motor/action) is a high-back chair,
which is a high-seat chair with a sculpted or a waterfall back
that provides a two-way, tilt-in-space action that gives high leg
elevation as the seat to back angle remains constant. The tilt in
space can be controlled manually or through a handset. It can
also have liH and tilt actions;
• riser: a recliner chair (dual motor/action) is a high-back
chair, which is a high-seat chair with a sculpted or waterfall
back, utilising two motors, operated by a handset to allow
independent leg rest and backrest operation. The backrest can
be reclined virtually flat as the backrest opens away from the
seat. It can also have liH and tilt actions;
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• hybrid specialist seating: manual or dynamic seating systems
that provide positioning and postural management for people
who are at risk of developing an asymmetrical body shape,
unable to maintain a midline position and require additional
postural support. The seating can be adjusted for the correct
seat height, seat depth, seat width, arm height, and back height
combined with headrest angle adjustment, back angle recline,
tilt-in-space, and leg rest elevation. Pressure redistributing seat
cushions can be integrated into the chair;
• bespoke custom-configured seating to accommodate more
complex postures or skin integrity needs that cannot be met
with oC-the-shelf seating solutions;
• bespoke custom-moulded seating to accommodate the fixed
asymmetrical posture of people who require significant postural
support.
The number of diCerent static chairs with pressure redistributing
elements has increased exponentially since the publication of the
2008 Tissue Viability Seating Guidelines, despite no standardised
terminology, for example the UK NHS Supply Chain currently lists
307 static chairs ranging in cost from GBP 270 to GBP 2500 (NHS
Supply Chain 2019), and this excludes bespoke equipment e.g.
moulded seat inserts fitted to the person's requirements.
How the intervention might work
To reduce pressure ulcer risk when seated, static chairs aim to
reduce seating pressure around the ischial tuberosities (bony parts
of the buttocks), greater trochanters (widest part of the thigh), and
sacral (area at the top of the buttock crease) region (Reddy 2006).
However, attention should also be paid to other bony prominences,
such as shoulder blades, spinal processes, back of head, elbows,
and heels (Stephens 2017). The aim is that the support provided
by the chair minimises constant pressure allowing good blood flow
to the soH tissues, maintaining the metabolic needs of local cells,
and reducing the risk of ulceration (Jan 2010). Several approaches
are used in the development of static chairs to redistribute pressure
and prevent shear or friction forces. Features such as seat cushion
design; tilt-in-space or recline function, or both; and use of elevated
leg rests are all used in an attempt to address these concepts
(Stinson 2003; Michael 2007; RESNA 2009; Jan 2010; Jan 2013; NICE
2014). However, much of the testing of these features has been
undertaken in wheelchair design and not static chair design.
Why it is important to do this review
Currently there is no systematic review focused on the evidence
for diCerent types of static chairs in pressure ulcer prevention
and there is a potential over-reliance on marketing material to
inform decision-making in this area. Given the widespread use of
static chairs with pressure redistributing technology in health and
social care settings, it is important to systematically review current
evidence for their eCects. Whilst previous reviews have focused
on cushions and wheelchairs, this Cochrane Review will consider
the diCerent types of static chairs and related seat moulds used in
health and social care contexts, the evidence for the eCectiveness
of these, and any outstanding uncertainty that may shape future
research and use of healthcare finances.
O B J E C T I V E S
To assess the eCects of pressure redistributing static chairs on the
prevention of pressure ulcers in health, rehabilitation, social care
settings, and places of residence in which people may spend their
day.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include published and unpublished randomised controlled
trials (RCTs), including cluster-RCTs, irrespective of language of
report. We will exclude quasi-randomised studies.
Types of participants
We will include studies in adults who remain seated for extended
periods of time, undertaken in any care setting: this might include
health, rehabilitation, social care settings, and places of residence
in which people may spend their day. We will include people at risk
of developing new pressure ulcers, which may include those with
existing pressure ulcers at baseline when pressure ulcer incidence
was measured in the study.
Types of interventions
We will include any type of pressure redistributing static chair. This
may include, but is not limited to: static arm chairs, riser recline
chairs, tilt-in-space chairs, recline chairs, and hybrid chairs. We are
not considering comparisons of static chairs with wheelchairs, or of
diCerent wheelchairs with each other in this review as wheelchairs
are mobility aids, nor is the focus of this review the eCects
of diCerent types of pressure redistributing cushions, as these
are included in a Cochrane Review focused on support surfaces
(McInnes 2015). We will include trials where the only systematic
diCerence between trial arms is the use of a specific static chair
type.
We anticipate that comparisons might include but not be limited to:
• pressure redistributing chairs compared with a standard chair
(used in a ward or residential setting) which may include:
* pressure redistributing static chair compared with standard
chair;
* pressure redistributing recline chair compared with standard
chair;
* pressure redistributing riser recline chair compared with
standard chair;
* pressure redistributing tilt in space chair compared with
standard chair;
* pressure redistributing hybrid chair compared with standard
chair;
• comparison of diCerent types of pressure redistributing chairs
which may include, but not be limited to, any combination of the
chair types noted above.
Classification of intervention type will be based on information
presented in the paper. Standard chairs used in a ward or
residential setting can have a high or low back, arm rests, front cross
bars (horizontal support element joining the legs), removable seat
cushions, custom-moulded seat inserts, with or without wings and
side infill. We will use study authors' definition of a standard chair
unless it is clear this is very diCerent to this general definition.
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Types of outcome measures
We list primary and secondary outcomes below. If a study is
otherwise eligible (i.e. correct study design, population, and
intervention/comparator) but does not report a listed outcome,
then we will contact the study authors where possible to establish
whether an outcome of interest here was measured but not
reported.
We will report outcome measures at the latest time point available
(assumed to be length of follow-up if not specified) and the time
point specified in the methods as being of primary interest (if this is
diCerent from the latest time point available). For all outcomes we
will class assessment of outcome measures as:
• < 1 week to 8 weeks as short term;
• > 8 weeks to 26 weeks as medium term; and
• > 26 weeks as long term.
Primary outcomes
Pressure ulcer incidence
• Proportion of participants developing a new pressure ulcer.
These data will include all incidence ulcers regardless of grade/
category (1 to 4);
• time-to-pressure ulcer development, correctly analysed using
survival, time-to-event approaches. Mean time to event data will
not be extracted unless it is clear that all participants in the study
developed an ulcer (a scenario which we anticipate being highly
unlikely).
Secondary outcomes
• Participant health-related quality of life/health status:
(measured using a standardised generic questionnaire such as
EQ-5D (Herdman 2011), Short Form (SF)-36, (Ware 1992), SF-12
(Ware 1996), or SF-6 (Brazier 2002)). We will not include ad hoc
measures of quality of life that are unlikely to be validated and
would not be common to multiple trials;
• participant comfort: we are not aware of any validated scale for
patient comfort so this measure will be as reported by study
authors;
• cost eCectiveness: within-trial cost-eCectiveness analysis
comparing mean diCerences in eCects with mean cost
diCerences between the two study arms: data extracted will
be incremental mean cost per incremental gain in benefit
(incremental cost-eCectiveness ratios) or other combined
measures of cost and eCects.
• All reported adverse events. We will include data where
study authors have specified a clear method for collecting
adverse event data. Where available, we will extract data on
all serious and all non-serious adverse events as an outcome.
We will record where it is clear that events are reported at the
participant level or whether multiple events per person were
reported, and then if appropriate adjustments were made for
data clustering. We will consider the assessment of any event in
general defined as adverse by participants, health professionals,
or both.
Search methods for identification of studies
Electronic searches
We will search the following databases to retrieve reports of
relevant trials:
• the Cochrane Wounds Specialised Register (to present);
• the Cochrane Central Register of Controlled Trials (CENTRAL) in
the Cochrane Library (to latest issue);
• Ovid MEDLINE (from 1946 to present);
• Ovid MEDLINE (In-Process & Other Non-Indexed Citations);
• Ovid Embase (from 1974 to present);
• EBSCO CINAHL Plus (from 1937 to present).
We have devised a draH search strategy for CENTRAL which is
displayed in Appendix 1. We will adapt this strategy to search
the Cochrane Wounds Specialised Register, Ovid MEDLINE, Ovid
Embase and EBSCO CINAHL Plus. We will combine the Ovid
MEDLINE search with the Cochrane Highly Sensitive Search
Strategy for identifying randomised trials in MEDLINE: sensitivity-
and precision-maximising version (2008 revision) (Lefebvre 2019).
We will combine the Embase search with the Ovid Embase filter
terms developed by the UK Cochrane Centre (Lefebvre 2019). We
will combine the CINAHL Plus search with the trial filter developed
by Glanville 2019. There will be no restrictions of the searches by
language, date of publication or study setting.
We will also search the following clinical trials registries for ongoing
studies:
• ClinicalTrials.gov (www.clinicaltrials.gov);
• WHO International Clinical Trials Registry Platform
(www.who.int/trialsearch).
Searching other resources
We aim to identify other potentially eligible trials or ancillary
publications by searching the reference lists of retrieved included
trials, as well as relevant systematic reviews, meta-analyses, and
health-technology assessment reports.
When necessary, we will contact experts in wound care and medical
devices to enquire about unpublished, ongoing, and recently
published trials.
We will not perform a separate search for adverse eCects of chair
use. We will consider adverse eCects described in included studies
only.
Data collection and analysis
Selection of studies
Two review authors will independently assess the titles and
abstracts of the citations retrieved by the searches for relevance.
AHer this initial assessment, we will obtain full-text copies of
all studies considered to be potentially relevant. Two review
authors will independently check the full papers for eligibility;
disagreements will be resolved by discussion and, where required,
the input of a third review author. Where required and possible, we
will contact study authors where the eligibility of a study is unclear.
We will record all reasons for exclusion of studies for which we
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had obtained full copies. We will complete a PRISMA flowchart to
summarise this process (Liberati 2009).
Where studies have been reported in multiple publications/reports,
we will obtain all publications. Whilst we will include each study
only once in the review, we will extract data from all reports to
ensure we obtain maximal relevant data.
Data extraction and management
We will extract and summarise details of the eligible studies using
a data extraction sheet. Two review authors will extract data
independently and will resolve disagreements by discussion, and
will consult a third review author where required. Where data are
missing from reports, we will attempt to contact the study authors
to obtain these. Where we have included a study with more than
two intervention arms, we will only extract data from intervention
and control groups that meet the eligibility criteria.
We will extract the following data where possible by treatment
group for the pre-specified interventions and outcomes in this
review. We will collect outcome data for relevant time points as
described in the Types of outcome measures section:
• country of origin;
• type of setting;
• trial design and unit of randomisation: was randomisation
undertaken the participant level or at the level of a ward, care
home, or other location;
• unit of analysis: how were clustered data addressed in the
analysis;
• care setting;
• number of participants randomised to each trial arm;
• eligibility criteria and key baseline participant data (participant
age, gender, and skin status where recorded);
• details of treatment regimen received by each group;
• duration of treatment;
• details of any co-interventions;
• primary and secondary outcome(s) (with definitions);
• outcome data for primary and secondary outcomes (by group);
• duration of follow-up;
• number of withdrawals (by group);
• publication status of study; and
• source of funding for trial.
Assessment of risk of bias in included studies
Two review authors will independently assess the risk of bias
in included studies by using the Cochrane 'Risk of bias' tool
(Higgins 2011a). This tool addresses six specific domains: sequence
generation, allocation concealment, blinding, incomplete data,
selective outcome reporting, and other issues. In this review we
will record issues with unit of analysis, for example where a
cluster-randomised trial has been undertaken but analysed at the
individual level in the study report (Appendix 1). We will assess
blinding and completeness of outcome data for each of the review
outcomes separately. We note that, since pressure ulcer incidence
is a subjective outcome, it can be at high risk of measurement bias
when outcome assessment is not blinded. We will consider studies
without blinded outcome assessment of ulcer incidence at high risk
of detection bias. It will be unlikely that studies are able to blind
health professionals or patients to treatment received, meaning
that most or all studies will be regarded as being at high risk of
performance bias. However, where studies have documented their
processes to minimise diCerences in performance, for example
with protocol-guided delivery of co-interventions, we may make
a judgement of unclear or low risk of bias. We will present our
assessment of risk of bias using two 'Risk of bias' summary figures:
one will be a summary of bias for each item across all studies, and
the second will show a cross-tabulation of each trial by all 'Risk of
bias' items. We will class studies with an assessment of low risk of
bias for selection bias (both domains of sequence generation and
allocation concealment), detection bias, and attrition bias, and no
assessment of high risk of bias in any other domain, to be at overall
low risk of bias (for specified outcome). Studies with a high risk of
bias assessment in any domains will be classed as being at high risk
of bias.
For cluster-randomised trials, we will also consider the risk of bias
in terms of: recruitment bias, baseline imbalance, loss of clusters,
incorrect analysis, and comparability with individually randomised
trials (Higgins 2011b; Appendix 2).
Measures of treatment e9ect
For dichotomous outcomes we will calculate the risk ratio (RR)
with 95% confidence intervals (CI). For continuously distributed
outcome data we will use the mean diCerence (MD) with 95% CIs,
if all trials use the same or similar assessment scale. If trials use
diCerent assessment scales, we will use the standardised mean
diCerence (SMD) with 95% CIs. We will only consider mean or
median time to healing without survival analysis as a valid outcome
if reports specify that all wounds healed (i.e. if the trial authors
regarded time to healing as a continuous measure as there is no
censoring). We will report time-to-event data (e.g. time-to-pressure
ulceration), as hazard ratios (HR) where possible in accordance with
the methods described in the Cochrane Handbook for Systematic
Reviews of Interventions (Deeks 2011). If studies reporting time-to-
event data do not report an HR, then, where feasible, we plan to
estimate this using other reported outcomes, such as the numbers
of events, through the application of available statistical methods
(Parmar 1998).
Unit of analysis issues
Some studies randomise by participant, but analyse outcomes by
wound. Where this occurs and the numbers of participants and
wounds are equal (i.e. one wound per participant), we will treat
the participant as the unit of analysis. There may be instances
of clustered data, where a proportion of trial participants have
outcome data collected and reported on multiple wounds. Since
not all participants will have multiple wounds this is not a cluster
trial per se, but rather a trial that incorrectly includes a mixture
of individual and clustered data. We will note such trials and will
record the issue in the 'Risk of bias' assessment. Data will be
extracted and presented, but will not be the subject of any further
analyses.
We will only incorporate correctly designed and analysed full
cluster trials into meta-analyses. Where a cluster-randomised trial
has been conducted but incorrectly analysed, we will record this in
the 'Risk of bias' assessment. If it is possible, we will approximate
the correct analyses with guidance from the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011b), using
information on:
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• the number of clusters randomised to each intervention, or the
mean size of each cluster;
• outcome data ignoring cluster design for the total number of
individuals; and
• an estimate of the intracluster correlation coeCicient (ICC).
If we cannot analyse the study data correctly, we will extract and
present the data without further analysis.
We will ensure there are no unit of analysis issues with double
counting of controls when using studies with multiple intervention
arms.
Where repeated observations are recorded on the same participant
(e.g. comfort scales over time), we will define time points and
analyse accordingly. Where multiple recordings are available within
these time points we will incorporate all available data for an
overall mean where possible.
Dealing with missing data
It is common for there to be to data missing from trial reports.
Excluding participants post-randomisation from the analysis, or
ignoring those participants who are lost to follow-up compromises
the randomisation, and potentially introduces bias into the trial.
Where there are missing data that we think should be included in
the analyses, we will contact the relevant study authors to request
these data.
Where data remain missing for the 'proportion of participants
developing a new pressure ulcer' outcome, for analysis we will
assume that if randomised participants were not included in an
analysis, they did not have an incident ulcer (i.e. they would
be considered in the denominator but not the numerator). We
will explore this in a sensitivity analysis where the impact of no
imputation (complete case analysis) is considered (see Sensitivity
analysis).
In a time-to-pressure ulceration analysis using survival analysis
methods, drop-outs should be accounted for as censored data and
we will not take any action regarding missing data.
For all secondary outcomes we will present available data from
the study reports/study authors and do not plan to impute missing
data. Where measures of variance are missing, we will calculate
these where possible. If calculation is not possible, we will contact
the study authors for further information. Where these measures
of variance are not available, we will exclude the study from any
relevant meta-analyses that we conduct.
Assessment of heterogeneity
Assessment of heterogeneity can be a complex, multi-faceted
process. Firstly, we will consider clinical and methodological
heterogeneity, that is the degree to which the included studies vary
in terms of participant, intervention, outcome, and characteristics
such as length of follow-up. We will supplement this assessment
of clinical and methodological heterogeneity by information
regarding statistical heterogeneity - assessed using the Chi2 test
(we will consider a significance level of P < 0.10 to indicate
statistically significant heterogeneity) in conjunction with the I2
measure (Higgins 2003). The I2 statistic examines the percentage of
total variation across RCTs that is due to heterogeneity rather than
chance (Higgins 2003). In general, I2 values of 25% or less may mean
a low level of heterogeneity (Higgins 2003), and values of more than
75% indicate very high heterogeneity (Deeks 2011). Where there
is evidence of high heterogeneity we will attempt to explore this
further (see Data synthesis).
Assessment of reporting biases
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results. Publication bias
is one of a number of possible causes of 'small study eCects', that
is, a tendency for estimates of the intervention eCect to be more
beneficial in smaller RCTs. Funnel plots allow a visual assessment
of whether small study eCects may be present in a meta-analysis.
A funnel plot is a simple scatter plot of the intervention eCect
estimates from individual RCTs against some measure of each trial’s
size or precision (Sterne 2011). We plan to present funnel plots for
meta-analyses comprising 10 RCTs or more using Review Manager
5 (RevMan 5) (Review Manager 2014).
Data synthesis
We will combine details of included studies in a narrative review
according to type of comparator, possibly by location/type of
wound, and then by outcomes by time period. We will consider
clinical and methodological heterogeneity and will undertake
pooling when studies appear appropriately similar in terms of
wound type, intervention type, duration of follow-up, and outcome
type.
We cannot pre specify the amount of clinical, methodological, and
statistical heterogeneity in the included studies, but it may be
extensive. Thus, we anticipate using a random-eCects approach for
meta-analysis. Conducting meta-analysis with a fixed-eCect model
in the presence of even minor heterogeneity may provide overly
narrow CIs. We will only use a fixed-eCect approach when clinical
and methodological heterogeneity is assessed to be minimal,
and the assumption that a single underlying treatment eCect is
being estimated holds. We will use Chi2 and I2 tests to quantify
heterogeneity but we will not used these to guide choice of model
for meta-analysis. We will exercise caution when meta-analysed
data are at risk of small study eCects because a random-eCects
model may be unsuitable. In this case, or where there are other
reasons to question the selection of a fixed-eCect or random-eCects
model, we will assess the impact of the approach using sensitivity
analyses to compare results from alternate models. We will report
any evidence that suggests that the use of a particular model might
not be robust. We may meta-analyse even when there is thought to
be extensive heterogeneity. We will attempt to explore the causes
behind this using meta-regression, if possible (Thompson 1999).
We will present data using forest plots where possible. For
dichotomous outcomes we will present the summary estimate as
a risk ratio (RR) with 95% CI. Where continuous outcomes are
measured in the same way across studies, we plan to present
a pooled mean diCerence (MD) with 95% CI; we plan to pool
standardised mean diCerence (SMD) estimates where studies
measure the same outcome using diCerent methods. For time-to-
event data, we plan to plot (and, if appropriate, pool) estimates
of HRs and 95% CIs as presented in the study reports using the
generic inverse variance method in RevMan 5 (Review Manager
2014). Where time-to-pressure ulcer development is analysed as a
continuous measure but it is not clear if all participants develop a
pressure ulcer (an unlikely scenario), we will document use of the
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outcome in the study but we will not summarise data or use them
in any meta-analysis.
We will obtain pooled estimates of treatment eCect using RevMan
5 (Review Manager 2014).
'Summary of findings' tables and assessment of the certainty
of evidence
We will present the main results of the review in 'Summary of
findings' tables, at this stage we anticipate including data from
all comparisons in 'Summary of findings' tables. These tables
present key information concerning the certainty of the evidence,
the magnitude of the eCects of the interventions examined, and
the sum of the available data for the main outcomes (Schünemann
2011a). The 'Summary of findings' tables also include an overall
grading of the evidence related to each of the main outcomes using
the GRADE approach. The GRADE approach defines the certainty
of a body of evidence as the extent to which one can be confident
that an estimate of eCect or association is close to the true quantity
of specific interest. The certainty of a body of evidence involves
consideration of within-trial risk of bias (methodological quality),
directness of evidence, heterogeneity, precision of eCect estimates,
and risk of publication bias (Schünemann 2011b). We plan to
present the following outcomes in the 'Summary of findings' tables:
• proportion of participants developing a new pressure ulcer;
• time to complete ulcer development where analysed using
appropriate survival analysis method;
• participant health-related quality of life/health status;
• participant comfort;
• cost eCectiveness.
For review outcomes reported for comparisons not listed above, we
will present a GRADE assessment without a 'Summary of findings'
table.
When evaluating the 'Risk of bias' domain, we will downgrade
the GRADE assessment only when we classified a study as being
at high risk of bias for one or more domains, or when the 'Risk
of bias' assessment for selection bias is unclear (i.e. classified as
unclear for either the generation of the randomisation sequence
or the allocation concealment domain). We will not downgrade for
unclear 'Risk of bias' assessments in other domains.
We will select an informal optimal information size of 300 for binary
outcomes, following the GRADE default value (Guyatt 2011). We
will follow GRADE guidance and downgrade twice for imprecision
when there are very few events and CIs around eCects included
both appreciable benefit and appreciable harm (considered GRADE
'default' of below 0.75 and above 1.25).
For calculating absolute risk diCerences for dichotomous and time-
to-event outcomes, we will use the median of the risks in the control
groups at particular time points.
Subgroup analysis and investigation of heterogeneity
Whilst we anticipate conducting an analysis of pressure
redistributing chairs compared with standard chairs, we will assess
potential heterogeneity across the following areas; specifically the
type of pressure redistribution chair being used. Where there is
evidence of between-trial heterogeneity, we envisage that we will
conduct a subgroup analysis by chair type.
Where possible we will also present a subgroup analysis of trials
which will include incidence of all grade of ulcers compared with
trials which only measured ulcers of grade 2 and above.
Where possible we will perform subgroup analyses of the overall
risk of bias category of a study (a binary comparison of: studies at
low or unclear risk of bias compared with studies classed at high
risk of bias).
Sensitivity analysis
Where possible we plan to perform sensitivity analyses to explore
the eCect of the following criteria:
• use of a fixed-eCect versus a random-eCects model;
• impact of missing data: our base case analysis will assume that
participants with missing data did not develop new pressure
ulcers. In this sensitivity analysis we will explore the impact of
this assumption undertaking the analysis with complete case
data only.
We have based elements of this Methods section on the standard
Cochrane Wounds protocol template.
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A P P E N D I C E S
Appendix 1. Risk of bias assessment (individually randomised controlled trials)
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using a
computer random number generator; coin tossing; shuCling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule based
on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
InsuCicient information about the sequence generation process provided to permit a judgement of low or high risk of bias.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method,
was used to conceal allocation: central allocation (including telephone, internet-based, and pharmacy-controlled randomisation);
sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.
High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: use of an open random allocation schedule (e.g. a list of random numbers); assignment envelopes without appropriate
safeguards (e.g. envelopes were unsealed, non-opaque, or not sequentially numbered); alternation or rotation; date of birth; case record
number; any other explicitly unconcealed procedure.
Unclear
InsuCicient information provided to permit a judgement of low or high risk of bias. This is usually the case if the method of concealment
is not described, or not described in suCicient detail to allow a definite judgement, for example if the use of assignment envelopes is
described, but it remains unclear whether envelopes were sequentially numbered, opaque, and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following:
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of
blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of others
unlikely to introduce bias.
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High risk of bias
Any one of the following:
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
Either of the following:
• InsuCicient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following:
• No missing outcome data.
• Reasons for missing outcome data are unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).
• Missing outcome data are balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is not enough to have a
clinically relevant impact on the intervention eCect estimate.
• For continuous outcome data, a plausible eCect size (diCerence in means or standardised diCerence in means) among missing outcomes
is not enough to have a clinically relevant impact on the observed eCect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
Any one of the following:
• Reason for missing outcome data are likely to be related to the true outcome, with either an imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is enough to induce
clinically relevant bias in the intervention eCect estimate.
• For continuous outcome data, a plausible eCect size (diCerence in means or standardised diCerence in means) among missing outcomes
is enough to induce a clinically relevant bias in the observed eCect size.
• 'As-treated' analysis done with a substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Either of the following:
• InsuCicient reporting of attrition/exclusions to permit a judgement of low or high risk of bias (e.g. number randomised not stated, no
reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Either of the following:
• The study protocol is available and all of the study’s prespecified (primary and secondary) outcomes that are of interest in the review
have been reported in the prespecified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were
prespecified (convincing text of this nature may be uncommon).
High risk of bias
Any one of the following:
Pressure redistributing static chairs for preventing pressure ulcers (Protocol)









Cochrane Database of Systematic Reviews
• Not all of the study’s prespecified primary outcomes have been reported.
• One or more primary outcomes is/are reported using measurements, analysis methods, or subsets of the data (e.g. subscales) that were
not prespecified.
• One or more reported primary outcomes was/were not prespecified (unless clear justification for their reporting is provided, such as
an unexpected adverse eCect).
• One or more outcomes of interest in the review is/are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
InsuCicient information provided to permit a judgement of low or high risk of bias. It is likely that most studies will fall into this category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• has been claimed to have been fraudulent; or
• had some other problem.
Unclear
There may be a risk of bias, but there is either:
• insuCicient information to assess whether an important risk of bias exists; or
• insuCicient rationale or evidence that an identified problem will introduce bias.
Appendix 2. Risk of bias (cluster-randomised controlled trials)
In cluster-randomised trials, particular biases to consider include: (i) recruitment bias; (ii) baseline imbalance; (iii) loss of clusters; (iv)
incorrect analysis; and (v) comparability with individually randomised trials.
(i) Recruitment bias can occur when individuals are recruited to the trial aHer the clusters have been randomised, as the knowledge of
whether each cluster is an ‘intervention’ or ‘control’ cluster could aCect the types of participants recruited.
(ii) Cluster-randomised trials oHen randomise all clusters at once, so lack of concealment of an allocation sequence should not usually be
an issue. However, because small numbers of clusters are randomised, there is a possibility of chance baseline imbalance between the
randomised groups, in terms of either the clusters or the individuals. Although not a form of bias as such, the risk of baseline diCerences can
be reduced by using stratified or pair-matched randomisation of clusters. Reporting of the baseline comparability of clusters, or statistical
adjustment for baseline characteristics, can help reduce concern about the eCects of baseline imbalance.
(iii) Occasionally complete clusters are lost from a trial, and have to be omitted from the analysis. Just as for missing outcome data in
individually randomised trials, this may lead to bias. In addition, missing outcomes for individuals within clusters may also lead to a risk
of bias in cluster randomised trials.
(iv) Many cluster randomised trials are analysed by incorrect statistical methods, not taking the clustering into account. Such analyses
create a ‘unit of analysis error’ and produce over-precise results (the standard error of the estimated intervention eCect is too small) and
P values that are too small. They do not lead to biased estimates of eCect. However, if they remain uncorrected, they will receive too much
weight in a meta-analysis.
(v) In a meta-analysis including both cluster and individually randomised trials, or including cluster-randomised trials with diCerent types
of clusters, possible diCerences between the intervention eCects being estimated need to be considered. For example, in a vaccine trial
of infectious diseases, a vaccine applied to all individuals in a community would be expected to be more eCective than if the vaccine was
applied to only half of the people. Another example is provided by a Cochrane Review of hip protectors (Hahn 2005). The cluster trials
showed large positive eCect whereas individually randomised trials did not show any clear benefit. One possibility is that there was a
‘herd eCect’ in the cluster-randomised trials (which were oHen performed in nursing homes, where compliance with using the protectors
may have been enhanced). In general, such ‘contamination’ would lead to underestimates of eCect. Thus, if an intervention eCect is still
demonstrated despite contamination in those trials that were not cluster randomised, a confident conclusion about the presence of an
eCect can be drawn. However, the size of the eCect is likely to be underestimated. Contamination and ‘herd eCects’ may be diCerent for
diCerent types of cluster.
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Appendix 3. Cochrane Central Register of Controlled Trials (CENTRAL) draI search strategy
#1 MeSH descriptor: [Pressure Ulcer] explode all trees
#2 (pressure next (ulcer* or sore* or injur*)):ti,ab,kw
#3 (decubitus next (ulcer* or sore*)):ti,ab,kw
#4 (bedsore* or bed sore*):ti,ab,kw
#5 #1 or #2 or #3 or #4
#6 MeSH descriptor: [Wheelchairs] explode all trees
#7 MeSH descriptor: [Posture] explode all trees
#8 MeSH descriptor: [Ergonomics] explode all trees
#9 (wheelchair* or wheel-chair* or chair* or armchair* or arm-chair* or seat or seats or seated or seating or sit or sitting):ti,ab,kw
#10 (riser-recline* or (riser recline*)):ti,ab,kw
#11 (tilt-in-space):ti,ab,kw
#12 (backrest* or back-rest* or armrest* or arm-rest* or legrest* or leg-rest*):ti,ab,kw
#13 #6 or #7 or #8 or #9 or #10 or #11 or #12
#14 #5 and #13
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